Prostate cancer Board decisions

The Board denied service connection for toe amputation, diabetes, high blood pressure, kidney disease, and prostate cancer as they were not shown to have begun in service or be related to service, including by exposure to contaminated water at Camp Lejeune.

The Board granted service connection for prostate cancer on a basis other than as pursuant to the PACT Act, including due to exposure to herbicide agents.

The Board denied service connection for diabetes mellitus, prostate cancer, and an increased rating for other specified trauma- and stressor-related disorder. The Veteran's claims for service connection for degenerative joint disease of multiple joints were remanded.

The Board granted service connection for the cause of the Veteran's death, specifically prostate cancer, and accrued benefits based on a pending claim for esophageal cancer due to presumed exposure to herbicide agents during service.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted a total disability rating based on individual unemployability due to the Veteran's service-connected disabilities.

The Board denied service connection for prostate cancer, finding no reasonable possibility that the Veteran's condition was due to in-service exposure to ionizing radiation.

The Board denied the Veteran's claim for an increased initial rating for prostate cancer residuals, finding that a compensable rating was not warranted prior to September 18, 2023.

The Board granted service connection for residuals of prostate cancer and hypertension, both presumed to be due to in-service herbicide agent exposure.

The Board denied earlier effective dates for the awards of service connection for prostate cancer, erectile dysfunction, and a scar, as well as special monthly compensation based on loss of use of creative organ.

The Board denied service connection for prostate cancer, hypertension, and a gallbladder disability as there is no evidence of current disabilities at any time during or approximate to the pendency of the claims.

The Board granted the appeals, restoring service connection for ischemic heart disease, supraventricular arrhythmia, and hypertension, and granting service connection for prostate cancer.

The Board granted the restoration of a 100 percent rating for prostate cancer, effective November 1, 2024.

The Board granted a 100 percent disability rating for prostate cancer, rendering the claim for TDIU moot.

The Board denied service connection for prostate cancer as it did not originate in service, within a year of service, and is not otherwise etiologically related to the Veteran's active duty service.

The Board granted service connection for prostate cancer, a condition presumed to be related to in-service exposure to Agent Orange.

The Board denied service connection for right lower extremity radiculopathy, denied earlier effective dates for prostate cancer residuals and major depressive disorder, denied increased ratings for CKD, tinnitus, and hearing loss, denied a higher rating for depression, and denied an earlier effective date for prostate cancer residuals. The Board granted TDIU and an earlier effective date for chronic kidney disease.

The Board granted an effective date of May 6, 2021 for the grant of service connection for prostate cancer acinar adenocarcinoma based on direct service connection.

The Veteran is entitled to service connection for prostate cancer, lower abdominal surgical scar, and erectile dysfunction from September 24, 2019.

The Board denied an evaluation in excess of 20 percent for residuals of prostate cancer prior to April 18, 2024 and in excess of 60 percent thereafter, as well as a compensable evaluation for an abdominal scar resulting from prostate cancer. The claim for service connection for basal cell carcinoma was remanded.